IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-31866-4.html
   My bibliography  Save this article

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Author

Listed:
  • Lino Möhrmann

    (National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ)
    NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden
    German Cancer Consortium (DKTK))

  • Maximilian Werner

    (National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ))

  • Małgorzata Oleś

    (Computational Oncology Group, NCT Heidelberg and DKFZ
    NCT Heidelberg and DKFZ)

  • Andreas Mock

    (NCT Heidelberg and DKFZ
    NCT Heidelberg and Heidelberg University Hospital)

  • Sebastian Uhrig

    (Computational Oncology Group, NCT Heidelberg and DKFZ
    Molecular Precision Oncology Program, NCT Heidelberg)

  • Arne Jahn

    (NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden
    German Cancer Consortium (DKTK)
    University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden)

  • Simon Kreutzfeldt

    (NCT Heidelberg and DKFZ)

  • Martina Fröhlich

    (Computational Oncology Group, NCT Heidelberg and DKFZ
    Molecular Precision Oncology Program, NCT Heidelberg)

  • Barbara Hutter

    (Computational Oncology Group, NCT Heidelberg and DKFZ
    Molecular Precision Oncology Program, NCT Heidelberg)

  • Nagarajan Paramasivam

    (Computational Oncology Group, NCT Heidelberg and DKFZ
    Molecular Precision Oncology Program, NCT Heidelberg)

  • Daniela Richter

    (National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK))

  • Katja Beck

    (Molecular Precision Oncology Program, NCT Heidelberg)

  • Ulrike Winter

    (Molecular Precision Oncology Program, NCT Heidelberg)

  • Katrin Pfütze

    (Molecular Precision Oncology Program, NCT Heidelberg)

  • Christoph E. Heilig

    (NCT Heidelberg and DKFZ)

  • Veronica Teleanu

    (NCT Heidelberg and DKFZ)

  • Daniel B. Lipka

    (NCT Heidelberg and DKFZ
    NCT Heidelberg and DKFZ)

  • Marc Zapatka

    (Division of Molecular Genetics, DKFZ)

  • Dorothea Hanf

    (National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ)
    NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden)

  • Catrin List

    (National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ)
    NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden)

  • Michael Allgäuer

    (University Hospital Heidelberg)

  • Roland Penzel

    (University Hospital Heidelberg)

  • Gina Rüter

    (Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin)

  • Ivan Jelas

    (Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin)

  • Rainer Hamacher

    (West German Cancer Center, University Hospital Essen
    DKTK)

  • Johanna Falkenhorst

    (West German Cancer Center, University Hospital Essen
    DKTK)

  • Sebastian Wagner

    (Hematology/Oncology, Goethe University
    DKTK)

  • Christian H. Brandts

    (Hematology/Oncology, Goethe University
    DKTK)

  • Melanie Boerries

    (Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg
    DKTK)

  • Anna L. Illert

    (DKTK
    Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg)

  • Klaus H. Metzeler

    (University Hospital, LMU Munich and Comprehensive Cancer Center
    University Hospital Leipzig)

  • C. Benedikt Westphalen

    (University Hospital, LMU Munich and Comprehensive Cancer Center)

  • Alexander Desuki

    (University Cancer Center Mainz, University Medical Center Mainz
    DKTK)

  • Thomas Kindler

    (University Cancer Center Mainz, University Medical Center Mainz
    DKTK)

  • Gunnar Folprecht

    (NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden)

  • Wilko Weichert

    (Technical University Munich)

  • Benedikt Brors

    (NCT Heidelberg and DKFZ)

  • Albrecht Stenzinger

    (University Hospital Heidelberg)

  • Evelin Schröck

    (NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden
    German Cancer Consortium (DKTK)
    University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden)

  • Daniel Hübschmann

    (Computational Oncology Group, NCT Heidelberg and DKFZ
    Molecular Precision Oncology Program, NCT Heidelberg
    Pattern Recognition and Digital Medicine, Heidelberg Institute for Stem cell Technology and Experimental Medicine
    DKTK)

  • Peter Horak

    (NCT Heidelberg and DKFZ
    DKTK)

  • Christoph Heining

    (National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ)
    NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden
    German Cancer Consortium (DKTK))

  • Stefan Fröhling

    (NCT Heidelberg and DKFZ
    DKTK)

  • Hanno Glimm

    (National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ)
    NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden
    German Cancer Consortium (DKTK)
    Translational Functional Cancer Genomics, NCT Heidelberg and DKFZ)

Abstract

The benefit of molecularly-informed therapies in cancer of unknown primary (CUP) is unclear. Here, we use comprehensive molecular characterization by whole genome/exome, transcriptome and methylome analysis in 70 CUP patients to reveal substantial mutational heterogeneity with TP53, MUC16, KRAS, LRP1B and CSMD3 being the most frequently mutated known cancer-related genes. The most common fusion partner is FGFR2, the most common focal homozygous deletion affects CDKN2A. 56/70 (80%) patients receive genomics-based treatment recommendations which are applied in 20/56 (36%) cases. Transcriptome and methylome data provide evidence for the underlying entity in 62/70 (89%) cases. Germline analysis reveals five (likely) pathogenic mutations in five patients. Recommended off-label therapies translate into a mean PFS ratio of 3.6 with a median PFS1 of 2.9 months (17 patients) and a median PFS2 of 7.8 months (20 patients). Our data emphasize the clinical value of molecular analysis and underline the need for innovative, mechanism-based clinical trials.

Suggested Citation

  • Lino Möhrmann & Maximilian Werner & Małgorzata Oleś & Andreas Mock & Sebastian Uhrig & Arne Jahn & Simon Kreutzfeldt & Martina Fröhlich & Barbara Hutter & Nagarajan Paramasivam & Daniela Richter & Kat, 2022. "Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31866-4
    DOI: 10.1038/s41467-022-31866-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-31866-4
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-31866-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Yang Shu & Weihan Zhang & Qianqian Hou & Linyong Zhao & Shouyue Zhang & Jiankang Zhou & Xiaohai Song & Yan Zhang & Dan Jiang & Xinzu Chen & Peiqi Wang & Xuyang Xia & Fei Liao & Dandan Yin & Xiaolong C, 2018. "Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer," Nature Communications, Nature, vol. 9(1), pages 1-11, December.
    2. Daniel B. Lipka & Tania Witte & Reka Toth & Jing Yang & Manuel Wiesenfarth & Peter Nöllke & Alexandra Fischer & David Brocks & Zuguang Gu & Jeongbin Park & Brigitte Strahm & Marcin Wlodarski & Ayami Y, 2017. "RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia," Nature Communications, Nature, vol. 8(1), pages 1-14, December.
    3. Peter Priestley & Jonathan Baber & Martijn P. Lolkema & Neeltje Steeghs & Ewart Bruijn & Charles Shale & Korneel Duyvesteyn & Susan Haidari & Arne Hoeck & Wendy Onstenk & Paul Roepman & Mircea Voda & , 2019. "Pan-cancer whole-genome analyses of metastatic solid tumours," Nature, Nature, vol. 575(7781), pages 210-216, November.
    4. Ludmil B. Alexandrov & Serena Nik-Zainal & David C. Wedge & Samuel A. J. R. Aparicio & Sam Behjati & Andrew V. Biankin & Graham R. Bignell & Niccolò Bolli & Ake Borg & Anne-Lise Børresen-Dale & Sandri, 2013. "Correction: Corrigendum: Signatures of mutational processes in human cancer," Nature, Nature, vol. 502(7470), pages 258-258, October.
    5. Michael S. Lawrence & Petar Stojanov & Paz Polak & Gregory V. Kryukov & Kristian Cibulskis & Andrey Sivachenko & Scott L. Carter & Chip Stewart & Craig H. Mermel & Steven A. Roberts & Adam Kiezun & Pe, 2013. "Mutational heterogeneity in cancer and the search for new cancer-associated genes," Nature, Nature, vol. 499(7457), pages 214-218, July.
    6. Ludmil B. Alexandrov & Serena Nik-Zainal & David C. Wedge & Samuel A. J. R. Aparicio & Sam Behjati & Andrew V. Biankin & Graham R. Bignell & Niccolò Bolli & Ake Borg & Anne-Lise Børresen-Dale & Sandri, 2013. "Signatures of mutational processes in human cancer," Nature, Nature, vol. 500(7463), pages 415-421, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ambrocio Sanchez & Pedro Ortega & Ramin Sakhtemani & Lavanya Manjunath & Sunwoo Oh & Elodie Bournique & Alexandrea Becker & Kyumin Kim & Cameron Durfee & Nuri Alpay Temiz & Xiaojiang S. Chen & Reuben , 2024. "Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    2. Anna Luiza Silva Almeida Vicente & Alexei Novoloaca & Vincent Cahais & Zainab Awada & Cyrille Cuenin & Natália Spitz & André Lopes Carvalho & Adriane Feijó Evangelista & Camila Souza Crovador & Rui Ma, 2022. "Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Martin Boström & Erik Larsson, 2022. "Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer," Nature Communications, Nature, vol. 13(1), pages 1-9, December.
    4. Jennifer B. Shah & Dana Pueschl & Bradley Wubbenhorst & Mengyao Fan & John Pluta & Kurt D’Andrea & Anna P. Hubert & Jake S. Shilan & Wenting Zhou & Adam A. Kraya & Alba Llop Guevara & Catherine Ruan &, 2022. "Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    5. Pengfei Yu & Can Hu & Guangyu Ding & Xiaoliang Shi & Jingli Xu & Yang Cao & Xiangliu Chen & Wei Wu & Qi Xu & Jingquan Fang & Xingmao Huang & Shaohua Yuan & Hui Chen & Zhizheng Wang & Ling Huang & Fei , 2024. "Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    6. Yaodong Zhang & Zijian Ma & Changxian Li & Cheng Wang & Wangjie Jiang & Jiang Chang & Sheng Han & Zefa Lu & Zicheng Shao & Yirui Wang & Hongwei Wang & Chenyu Jiao & Dong Wang & Xiaofeng Wu & Hongbing , 2022. "The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    7. Mei Lin & Xiao-Long Zhang & Rui You & You-Ping Liu & Hong-Min Cai & Li-Zhi Liu & Xue-Fei Liu & Xiong Zou & Yu-Long Xie & Ru-Hai Zou & Yi-Nuan Zhang & Rui Sun & Wei-Yi Feng & Hai-Yan Wang & Gui-Hua Tao, 2023. "Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    8. Johann-Christoph Jann & Maximilian Mossner & Vladimir Riabov & Eva Altrock & Nanni Schmitt & Johanna Flach & Qingyu Xu & Verena Nowak & Julia Obländer & Iris Palme & Nadine Weimer & Alexander Streuer , 2021. "Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    9. Eleanor L. Woodward & Minjun Yang & Larissa H. Moura-Castro & Hilda Bos & Rebeqa Gunnarsson & Linda Olsson-Arvidsson & Diana C. J. Spierings & Anders Castor & Nicolas Duployez & Marketa Zaliova & Jan , 2023. "Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    10. Mischan Vali-Pour & Solip Park & Jose Espinosa-Carrasco & Daniel Ortiz-Martínez & Ben Lehner & Fran Supek, 2022. "The impact of rare germline variants on human somatic mutation processes," Nature Communications, Nature, vol. 13(1), pages 1-21, December.
    11. Xing Cheng & Jing An & Jitong Lou & Qisheng Gu & Weimin Ding & Gaith Nabil Droby & Yilin Wang & Chenghao Wang & Yanzhe Gao & Jay Ramanlal Anand & Abigail Shelton & Andrew Benson Satterlee & Breanna Ma, 2024. "Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    12. Michelle Dietzen & Haoran Zhai & Olivia Lucas & Oriol Pich & Christopher Barrington & Wei-Ting Lu & Sophia Ward & Yanping Guo & Robert E. Hynds & Simone Zaccaria & Charles Swanton & Nicholas McGranaha, 2024. "Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
    13. Marjan M. Naeini & Felicity Newell & Lauren G. Aoude & Vanessa F. Bonazzi & Kalpana Patel & Guy Lampe & Lambros T. Koufariotis & Vanessa Lakis & Venkateswar Addala & Olga Kondrashova & Rebecca L. John, 2023. "Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    14. Tara Muijlwijk & Irene H. Nauta & Anabel Lee & Kari J. T. Grünewald & Arjen Brink & Sonja H. Ganzevles & Robert J. Baatenburg de Jong & Lilit Atanesyan & Suvi Savola & Mark A. Wiel & Laura A. N. Pefer, 2024. "Hallmarks of a genomically distinct subclass of head and neck cancer," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    15. Brittany N. Vandenberg & Marian F. Laughery & Cameron Cordero & Dalton Plummer & Debra Mitchell & Jordan Kreyenhagen & Fatimah Albaqshi & Alexander J. Brown & Piotr A. Mieczkowski & John J. Wyrick & S, 2023. "Contributions of replicative and translesion DNA polymerases to mutagenic bypass of canonical and atypical UV photoproducts," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    16. Teresa Maria Rosaria Noviello & Anna Maria Giacomo & Francesca Pia Caruso & Alessia Covre & Roberta Mortarini & Giovanni Scala & Maria Claudia Costa & Sandra Coral & Wolf H. Fridman & Catherine Sautès, 2023. "Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    17. Qi Zhao & Feng Wang & Yan-Xing Chen & Shifu Chen & Yi-Chen Yao & Zhao-Lei Zeng & Teng-Jia Jiang & Ying-Nan Wang & Chen-Yi Wu & Ying Jing & You-Sheng Huang & Jing Zhang & Zi-Xian Wang & Ming-Ming He & , 2022. "Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    18. Ankur Chakravarthy & Ian Reddin & Stephen Henderson & Cindy Dong & Nerissa Kirkwood & Maxmilan Jeyakumar & Daniela Rothschild Rodriguez & Natalia Gonzalez Martinez & Jacqueline McDermott & Xiaoping Su, 2022. "Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    19. Oriol Pich & Iker Reyes-Salazar & Abel Gonzalez-Perez & Nuria Lopez-Bigas, 2022. "Discovering the drivers of clonal hematopoiesis," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    20. Francesca Menghi & Edison T. Liu, 2022. "Functional genomics of complex cancer genomes," Nature Communications, Nature, vol. 13(1), pages 1-4, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31866-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.